Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Surveillance for Cancer Incidence and Mortality — United States, 2013



Simple D. Singh, MD1; S. Jane Henley, MSPH1; A. Blythe Ryerson, PhD1 (View author affiliations)

View suggested citation

Preface

This report provides, in tabular and graphic form, official federal statistics on cancer incidence and mortality for 2013 and trends for 1999–2013 as reported by CDC and the National Cancer Institute (NCI). Data in this report come from the United States Cancer Statistics (USCS) system (1), which includes cancer incidence data from population-based cancer registries that participate in CDC’s National Program of Cancer Registries (NPCR) and NCI’s Surveillance, Epidemiology, and End Results (SEER) program reported as of November 2015 and cancer mortality data from death certificate information reported to state vital statistics offices as of June 2015 and compiled into a national file for the entire United States by CDC’s National Center for Health Statistics (NCHS) National Vital Statistics System (NVSS).

This report presents information on new cancer cases and deaths for 2013. The number and rate of cancer cases and deaths are stratified by the primary cancer sites as reported for 2013; information is provided by demographic characteristic (e.g., sex, age, race, and ethnicity) and primary cancer site (68 selected sites among men and 72 selected sites among women). Age-adjusted cancer incidence and death rates are shown by primary site and year for the period 1999–2013. Age-adjusted cancer incidence and death rates for the most common sites are shown by race, sex, and ethnicity for 2013, the most recent diagnosis year for which incidence data are available. Maps of the United States display age-adjusted cancer incidence and death rates, presented by quartiles, for 2013. Time trends in age-adjusted cancer incidence and death rates during 1999–2013 are shown for all sites combined, colorectal, lung and bronchus, prostate, and female breast by race, sex, and ethnicity.

Top

Background

Cancer comprises a diverse mix of diseases occurring in every part of the body and is a leading cause of death in the United States (2). More than half of cancer cases could be prevented (3). Surveillance of cancer incidence and mortality can help public health officials target areas for control efforts (4) and track progress toward meeting the national health objectives set forth in Healthy People 2020 (5). As of 2016, Healthy People 2020 objectives included reducing cancer deaths per 100,000 persons to 161.4 for all cancers, 45.5 for lung cancer, 20.7 for female breast cancer, 2.2 for cervical cancer, 14.5 for colorectal cancer, 2.3 for oropharyngeal cancer, 21.8 for prostate cancer, 2.4 for melanoma and reducing cancer incidence per 100,000 persons to 39.9 for colorectal cancer, 7.2 for cervical cancer, and 42.1 for late-stage female breast cancer (5).

Cancer is a reportable disease in every state and thus all hospitals, physicians’ offices, pathology laboratories, and other medical facilities are required to submit data on all reportable cancer diagnoses to a central cancer registry at the state or territorial level. A cancer registry is a database that contains individual records of all reportable cancer cases in a defined population and includes patient demographics, tumor characteristics (e.g., cancer site and pathology), and information about the notifying health provider or facility. Cancer control planners and others can identify variations in cancer rates by population subgroups and monitor trends over time to guide the planning and evaluation of cancer prevention and control programs and allocation of health resources.

Top

Data Sources

Data about cancer incidence and mortality come from the official federal statistics on cancer, the USCS dataset (1). The USCS dataset includes cancer incidence data from NPCR registries in 45 states and the District of Columbia (DC) (cancer incidence data from Puerto Rico and the U.S. Pacific Island Jurisdictions were not available for this analysis) and from SEER program registries in the remaining five states (Connecticut, Hawaii, Iowa, New Mexico, and Utah) and cancer mortality data from NVSS. Incidence data included in USCS have met publication criteria.

Incidence Data

The primary source of data on cancer incidence is medical records. Staff at medical facilities such as hospitals, doctors’ offices, and pathology laboratories abstract data from patients’ medical records, enter it into the facility’s own cancer registry if it has one, and then send the data to the regional or state registry. The data then are sent to the central cancer registry in that state, district or territory. Every year the central cancer registries electronically submit incidence, demographic, and clinical data to NPCR or SEER. Both NPCR and SEER registries collect data using uniform data items and codes as documented by the North American Association of Central Cancer Registries (NAACCR). This uniformity ensures that data items collected by the two federal programs are comparable (6,7). Information on primary site and histology is coded according to the International Classification of Diseases for Oncology, Third Edition (ICD-O-3) and categorized according to the revised SEER recodes dated January 27, 2003, which define standard groupings of primary cancer sites (https://seer.cancer.gov/siterecode) (8). Beginning with 2010 diagnoses, cases were first classified by anatomic site by using ICD-O-3; cases with hematopoetic histologies were further classified by using the 2008 World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues (9). Data from the NPCR registries provided in this report were reported to CDC as of November 30, 2015. Data from SEER registries were reported to NCI as of November 1, 2015.

NPCR and SEER cancer registries consider as reportable all incident cases with a behavior code of 2 (in situ, noninvasive) or 3 (malignant, primary site only) in ICD-O-3. Exceptions include in situ cancer of the cervix and all basal and squamous cell carcinomas of the skin, except for those on the skin of the genital organs (8). Beginning with 2001 diagnoses, several cancers that are coded as malignant in ICD-O-3 were not coded as malignant in ICD-O-2 (6). Additional information is provided in the USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria#nameddest=IncidenceDataSources).

Mortality Data

Cancer mortality statistics are based on information from all death certificates filed in the 50 states and DC and processed by NVSS at NCHS (10). The cancer mortality data were compiled in accordance with WHO regulations, which specify that member nations classify and code causes of death in accordance with the current revision of the International Classification of Diseases (ICD) (11). For consistency with the data on cancer incidence, the cancer sites in mortality data were grouped according to the revised SEER recodes dated January 27, 2003 (https://seer.cancer.gov/codrecode). Data for a specific calendar year are based on records of deaths that occurred during that calendar year and received by a particular date. Data in this report include, mortality data for 2013 based on records of deaths that occurred during 2013 and received by NCHS as of June 30, 2015. Data in this report come from USCS, which includes cancer deaths during 1998–2013; cancer mortality data for 2014 are available at https://www.cdc.gov/nchs/nvss/deaths.htm. Additional information about mortality data is provided in the USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria#nameddest=MortalityDataSources).

Population Estimates

Population denominators are annual race-specific, ethnicity-specific, and sex-specific county population estimates modified by NCI in collaboration with CDC’s NCHS from the U.S. Census intercensal (for July 1, 1999–2009) and Vintage 2014 (for July 1, 2010–2013) annual times series (12). Modifications incorporated bridged single-race estimates that are derived from the original multiple race categories in the 2000 and 2010 censuses. For most states, population estimates as of July 1 of each year were used to calculate annual incidence rates because these estimates are presumed to reflect the average population of a defined geographic area for a calendar year. However, some county population estimates were adjusted to account for populations displaced along the Gulf Coast of Louisiana, Alabama, Mississippi, and Texas in the fall of 2005 by hurricanes Katrina and Rita. The national total population estimates were not affected by these adjustments. Other specific modifications included using additional local information to accurately estimate the native Hawaiian population and deriving population estimates for newly created counties in Colorado and Alaska. The modified county-level population estimates, summed to the state and national level, were used as denominators in rate calculations. Additional details about population data are available at https://seer.cancer.gov/popdata/index.html.

Top

Publication Criteria

Cancer incidence data are derived from state cancer registries that have high-quality cancer incidence data for individual (e.g., 2013) and combined (e.g., 1999–2013) years as demonstrated by meeting all of the following criteria on data quality for all cancer sites combined:

  • case ascertainment is ≥90% (margin of error +5%) complete,

  • ≤5% of cases are ascertained solely on the basis of a death certificate,

  • ≤3% of cases are missing information on sex,

  • ≤3% of cases are missing information on age,

  • ≤5% of cases are missing information on race, and

  • ≥97% of the registry’s records passed a set computerized edits that test the validity and logic of data components.

In this report, cancer incidence data for 2013 include data from DC and all states except Nevada, covering 99% of the US population, and data for 1999–2013 include data from all registries except Arkansas, DC, Mississippi, Nevada, South Dakota, Tennessee, and Virginia, covering 92% of the U.S. population. Additional information about USCS is available at available at https://www.cdc.gov/uscs/.

Top

Interpreting Data

Incidence Data

Each year, state cancer registries submit cancer cases for a new diagnosis year and an updated version of the previous year’s cancer cases to CDC or NCI. Therefore, each year, when USCS data are published, updates to the previous year’s data are published, using the most recent data submission and the most recent population data. Users of cancer incidence data published by federal agencies need to be mindful of the date of data submission for data used in their analyses.

Mortality Data

Cancer mortality statistics in USCS are influenced by the accuracy of information on the death certificate. Unlike incidence data, mortality data for a calendar year are considered complete when submitted and so are not updated after the aggregate data file is released. Mortality data for the entire United States refer only to deaths that occurred within the United States; data for geographic areas are provided by the decedent’s place of residence.

Race and Ethnicity Data

Differences in rates among racial and ethnic populations should be interpreted with caution. For cancer incidence, race and ethnicity data are abstracted from medical records and grouped into categories (7). A study using SEER incidence data suggests that the quality of data on race/ethnicity in cancer registries is considered excellent for whites, blacks, and Asians/Pacific Islanders, good for Hispanics, and poor for American Indians/Alaska Natives (13). When cancer mortality is reported, race and ethnic origin are recorded separately on the death certificate by the funeral director as provided by an informant or, in the absence of an informant, on the basis of observation (14). Previous studies involving cancer mortality data demonstrate that death rates for whites and blacks generally are estimated accurately whereas death rates for Asians/Pacific Islanders, American Indians/Alaska Natives, and Hispanics are underestimated (2,15). Recent study involving evaluation of validity of race showed that classification of race and ethnicity on death certificates improved overtime for Asian/Pacific Islanders and Hispanics (now almost as good as whites and blacks), however, remained poor for American Indians/Alaska Natives (16). For this reason, incidence and mortality data provided in this report might be underestimated for American Indians/Alaska Natives groups, possibly because of misclassification of race.

Three NPCR registries (Delaware, Kansas, and Kentucky) opted not to present state-specific Asian/Pacific Islander counts and rates. Six NPCR registries (Delaware, Kentucky, Massachusetts, Pennsylvania, North Dakota, and Virginia) opted not to present state-specific Hispanic (classified by the NAACCR Hispanic Identification [NHIA] Algorithm) counts and rates (17). Cancer registries regularly link their database to the Indian Health Service patient registration dataset to reduce misclassification of race for American Indian/Alaska Native patients; in this report, 34 NPCR registries and all SEER registries linked cases diagnosed in 1999–2013. Six NPCR registries (Delaware, Illinois, Kansas, Kentucky, New Jersey, and New York) opted not to present state-specific American Indian/Alaska Native counts and rates. However, the aggregate national rates presented in this report include data for these registries, except that incidence rates by ethnicity exclude Virginia because ethnicity information was missing on 85% of cases from Virginia.

Population Coverage

The population coverage for incidence data varies by diagnosis year. Population coverage might be affected by the suppression of state incidence data if a state did not meet the publication criteria or did not submit data for that diagnosis year. In addition, state incidence data were suppressed in this report if <16 cases were reported or if the state requested that the data be suppressed. Additional information is provided by the USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria#nameddest=CensusRegionPubCriteria). Mortality data from malignant neoplasms (i.e., cancers) as recorded in NVSS from the 50 states and DC are available in USCS, and thus 100% of the U.S. population is covered each year. However, state death data were suppressed in this report if <16 deaths were reported.

Suppression of Rates and Counts

When the numbers of cases or deaths used to compute rates are small, those rates tend to have poor reliability. Therefore, incidence and death rates and counts of <16 are not shown in tables and figures. The use of a threshold value for suppressing cells helps protect the confidentiality of patients by reducing or eliminating the risk for disclosure of their identity and helps avoid overreliance on unstable data. Additional information is provided in the USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria#nameddest=Suppression).

Top

Highlights

Incidence and Death Rates

In 2013, more than 1.5 million invasive cancers were diagnosed in the United States, an annual incidence rate of 439 cases per 100,000 persons (Table 1). In the same year, approximately 584,872 persons died of cancer nationally, an annual death rate of 163 deaths per 100,000 persons (Table 2). Overall and for many cancer sites, males had higher incidence (Table 1) and death rates (Table 2) than did females.

Four cancer sites accounted for 48% of all cases diagnosed in 2013, including 230,815 female breast cancers, 212,584 lung and bronchus cancers (111,907 among men and 100,677 among women), 176,450 prostate cancers, and 136,119 colon and rectum cancers (71,099 among men and 65,020 among women) (Table 1). These four sites also accounted for 47% of cancer deaths in 2013, including 156,176 lung cancer deaths, 51,813 colon and rectum cancer deaths, 40,860 female breast cancer deaths, and 27,681 prostate cancer deaths (Table 2).

By state, overall (all cancer sites combined) cancer incidence rates in 2013 ranged from 364 to 512 cases per 100,000 persons (Table 3), and overall cancer death rates ranged from 128 to 199 deaths per 100,000 persons (Table 4). The Healthy People 2020 target (5) for overall cancer death rate (161.4 deaths per 100,000) has been reached in 21 states.

Cancer incidence (Table 5) and death (Table 6) rates increase with age. In 2013, among persons in the youngest age group (<15 years), 10,172 new cancer cases (rate: 17 cases per 100,000 persons) and 1,287 cancer deaths (rate: two deaths per 100,000 persons) were reported. Among persons aged ≥65 years, 851,505 new cancer cases (rate: 1,920 cases per 100,000 persons) and 407,558 cancer deaths (rate: 911 deaths per 100,000 persons) were reported. Overall, 55% of cancer cases and 70% of cancer deaths in 2013 occurred among persons aged ≥65 years.

In 2013, by race, blacks had the highest cancer incidence (Table 7) and death (Table 8) rates while American Indians/Alaska Natives had the lowest cancer incidence and Asians/Pacific Islanders had the lowest cancer death rates. By ethnicity, overall and for most cancer sites, Hispanics had lower cancer incidence (Table 9) and death rates (Table 10) than did non-Hispanics. Differences in cancer incidence (Figure 1) and death (Figure 2) rates by race and ethnicity might reflect differences in risk factors, screening, and treatment although rates among some populations might be under- or overestimated because of misclassification of race or ethnicity.

By state and site, cancer incidence rates in 2013 ranged from 69 to 131 per 100,000 males for prostate cancer, from 105 to 148 per 100,000 females for breast cancer, from 4 to 11 per 100,000 females for cervical cancer, from 26 to 93 per 100,000 persons for lung cancer, and from 32 to 49 per 100,000 persons for colorectal cancer (Figure 3). By state and site, cancer death rates in 2013 ranged from 12 to 33 per 100,000 males for prostate cancer, from 15 to 30 per 100,000 females for breast cancer, from 1 to 4 per 100,000 females for cervical cancer, from 19 to 70 per 100,000 persons for lung cancer, and from 11 to 20 per 100,000 persons for colorectal cancer (Figure 4).

Time Trends in Incidence and Death Rates

On the basis of data from registries meeting data quality criteria during 2004–2013, cancer incidence counts (Table 11) and rates (Table 12) are presented by state and year. Time trends in cancer incidence rates are presented by cancer site, sex, and race (Figure 5) and by cancer site, sex, and ethnicity (Figure 6). Cancer incidence rates declined from 484 cancer cases per 100,000 population in 1999 to 432 cases in 2013. Although lung cancer incidence declined steadily among men from 1999 to 2013, it increased among women from 1999 to 2005 and has since declined from 2005 to 2013. Prostate cancer incidence declined from 170 cases per 100,000 men in 1999 to 101 cases in 2013. Colorectal cancer incidence declined from 56 cases per 100,000 persons in 1999 to 38 cases in 2013. Female breast cancer incidence declined from 135 cases per 100,000 women in 1999 to 121 cases in 2005, increased to 126 cases in 2009, and declined again to 124 cases in 2013. Time trends in cancer death rates are presented by cancer site, sex, and race (Figure 7) and by cancer site, sex, and ethnicity (Figure 8). During 1999–2013, cancer death rates declined from 201 deaths per 100,000 persons in 1999 to 163 deaths in 2013; during the same period, death rates declined for each of the four most common cancers (Figure 5). Cancer death counts (Table 13) and rates (Table 14) are presented by state and year.

National cancer surveillance data help public health officials track progress toward achieving the national cancer objectives set forth in Healthy People 2020 (18). Differing rates of cancer by race, ethnicity, and state of residence indicate that for some populations, Healthy People 2020 objectives have already been achieved, whereas objectives for other populations have not been met. For the national cancer burden to be reduced and Healthy People 2020 targets to be met, behavioral and environmental factors that increase cancer risk must be reduced, and high-quality screening services, timely follow-up, and evidence-based treatments must be available and accessible to all persons. Cancer surveillance data can identify populations with high cancer rates that might benefit most from targeted cancer prevention and control efforts. Several effective evidence-based primary and secondary prevention measures, such as vaccination against infectious agents that cause cancer (i.e., hepatitis B virus and human papillomavirus), help with smoking cessation, and recommended cancer screening, when effectively implemented and sustained, could reduce the number of new cancer cases and prevent many cancer-related deaths (19). Evidence-based interventions can be implemented at both the individual level and the population level to reduce cancer risk factors, promote healthy living, and encourage cancer screening (3). The impact of these efforts can be monitored using cancer surveillance data.

Top

Acknowledgment

Data were provided by state and regional cancer registry personnel and health department personnel.

Top


Corresponding author: Simple Singh, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC. Telephone: 770-488-4292; E-mail: sdsingh@cdc.gov.

Top

1Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC

Top

References

  1. US Cancer Statistics Working Group. United States cancer statistics: 1999–2013. Incidence and mortality web-based report. Atlanta, GA: US Department of Health and Human Services, CDC, National Cancer Institute; 2016. https://www.cdc.gov/uscs
  2. Heron M. Deaths: leading causes for 2013. Natl Vital Stat Rep 2016;65:1–95. https://www.cdc.gov/nchs/data/nvsr/nvsr65/nvsr65_02.pdf PubMed
  3. Colditz GA, Wolin KY, Gehlert S. Applying what we know to accelerate cancer prevention. Sci Transl Med 2012;4:127rv4. CrossRef PubMed
  4. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975. J Natl Cancer Inst 2003;95:1276–99. CrossRef PubMed
  5. US Department of Health and Human Services. Healthy people 2020. Washington, DC: US Department of Health and Human Services; 2011. https://www.healthypeople.gov/2020/topicsobjectives2020/default.aspx
  6. Fritz ARL. The SEER program code manual. Bethesda, MD: National Cancer Institute; 1998.
  7. Thornton ML, ed. Standards for cancer registries. Volume II: data standards and data dictionary, record layout version 13, 17th ed. Springfield, IL: North American Association of Central Cancer Registries; 2012.
  8. Fritz A, Percy C, Jack A. International classification of diseases of oncology. Geneva, Switzerland: World Health Organization; 2000.
  9. National Cancer Institute. Hematopoietic codes based on WHO classification of tumours of haematopoietic and lymphoid tissues. Rockville, MD: US Department of Health and Human Services, National Cancer Institute; 2008. https://seer.cancer.gov/iccc
  10. Hetzel AM. Vital Statistics System: major activities and developments, 1950–95. Atlanta, GA: US Department of Health and Human Services, CDC, National Center for Health Statistics; 1997. PHS 97-1993.
  11. World Health Organization. International statistical classification of diseases and related health problems. 10th revision. Geneva, Switzerland: World Health Organization; 1992.
  12. National Cancer Institute. US population data 1969–2014. Revised March 2016. https://seer.cancer.gov/popdata/
  13. Clegg LX, Reichman ME, Hankey BF, et al. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 2007;18:177–87. CrossRef PubMed
  14. Miniño AM, Heron MP, Murphy SL, Kochanek KD. Deaths: final data for 2004. Natl Vital Stat Rep 2007;55:1–119. PubMed
  15. Arias E, Schauman WS, Eschbach K, Sorlie PD, Backlund E. The validity of race and Hispanic origin reporting on death certificates in the United States. Vital Health Stat 2 2008;(148):1–23. https://www.cdc.gov/nchs/data/series/sr_02/sr02_148.pdf PubMed
  16. Arias E, Heron M, Hakes JK. The validity of race and Hispanic-origin reporting on death certificates in the United States: an update. Vital Health Stat 2 2016;(172):1–22. https://www.cdc.gov/nchs/data/series/sr_02/sr02_172.pdf PubMed
  17. North American Association of Central Cancer Registries Asian Pacific Islander Work Group. NAACCR Asian Pacific Islander identification algorithm. Springfield, IL: North American Association of Central Cancer Registries; 2008.
  18. Henley SJ, Singh SD, King J, Wilson RJ, Ryerson AB. Invasive cancer incidence—United States, 2010. MMWR Morb Mortal Wkly Rep 2014;63:253–9.PubMed
  19. Agency for Healthcare Research and Quality. The guide to clinical preventive services, 2014. Rockville, MD: Agency for Healthcare Research and Quality; 2015. http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/guide/index.html

Top

Return to your place in the textTABLE 1. Reported number and rate* of invasive cancer cases, by primary cancer site and sex — United States, 2013§
Cancer siteMaleFemaleTotal
No.RateNo.RateNo.Rate
All sites combined781,451479.0777,679412.61,559,130439.0
Oral cavity and pharynx29,69317.412,0246.341,71711.5
Lip1,3990.95470.31,9460.6
Tongue9,1645.33,5921.912,7563.5
Salivary gland2,6291.71,7791.04,4081.3
Floor of mouth1,3680.86210.31,9890.5
Gum and other mouth3,0541.92,3921.25,4461.5
Nasopharynx1,2890.85210.31,8100.5
Tonsil6,5283.71,4150.77,9432.1
Oropharynx1,4590.84470.21,9060.5
Hypopharynx1,8931.14500.22,3430.6
Other oral cavity and pharynx9100.52600.11,1700.3
Digestive system155,53595.4124,18563.8279,72078.2
Esophagus12,9137.83,5191.816,4324.5
Stomach14,4299.08,7194.523,1486.6
Small intestine4,3072.63,8872.08,1942.3
Colon and rectum71,09944.265,02033.6136,11938.4
Colon excluding rectum48,17530.348,74825.096,92327.4
Rectum and rectosigmoid junction22,92413.916,2728.639,19611.0
Anus, anal canal, and anorectum2,4411.54,1362.16,5771.8
Liver and intrahepatic bile duct21,14312.08,3304.229,4737.9
Gallbladder1,2800.82,6541.33,9341.1
Other biliary3,4012.22,9791.56,3801.8
Pancreas22,78714.121,59010.944,37712.4
Retroperitoneum6230.46100.31,2330.4
Peritoneum, omentum, and mesentery1700.11,8040.91,9740.6
Other digestive organs9420.69370.51,8790.5
Respiratory system123,76076.9104,34853.4228,10863.6
Nose, nasal cavity, and middle ear1,4350.98950.52,3300.7
Larynx9,9235.92,5191.312,4423.4
Lung and bronchus111,90769.8100,67751.5212,58459.4
Pleura5704801050
Trachea, mediastinum, and other respiratory organs4380.32090.16470.2
Bones and joints1,6501.11,3340.82,9840.9
Soft tissue including heart6,0933.94,9652.811,0583.3
Skin excluding basal and squamous45,97729.031,93817.677,91522.4
Melanoma of the skin42,43026.629,51316.371,94320.7
Other nonepithelial skin3,5472.42,4251.35,9721.7
Male and female breastNANANANA232,92466.3
Female breastNANA230,815123.7NANA
Male breast2,1091.3NANANANA
Female genital systemNANA91,87248.6NANA
CervixNANA11,9557.2NANA
Corpus and uterus, NOSNANA50,56025.9NANA
CorpusNANA48,93725.0NANA
Uterus, NOSNANA1,6230.8NANA
OvaryNANA20,92711.2NANA
VaginaNANA1,2660.6NANA
VulvaNANA4,8952.6NANA
Other female genital organsNANA2,2691.2NANA
Male genital system186,509108.2NANANANA
Prostate176,450101.6NANANANA
Testis8,3515.5NANANANA
Penis1,3340.9NANANANA
Other male genital organs3740.2NANANANA
Urinary system91,83258.039,16320.3130,99536.9
Urinary bladder53,92134.917,0308.670,95120.0
Kidney and renal pelvis35,91421.721,03411.256,94816.0
Ureter1,1850.87220.41,9070.5
Other urinary organs8120.53770.21,1890.3
Eye and orbit1,5401.01,2710.72,8110.8
Brain and other nervous system12,0927.69,7565.521,8486.5
Brain11,4537.29,0365.120,4896.0
Cranial nerves other nervous system6390.47200.41,3590.4
Endocrine system13,0528.137,03322.250,08515.3
Thyroid11,8167.335,87721.647,69314.6
Other endocrine including thymus1,2360.81,1560.72,3920.7
Lymphomas40,05625.332,89917.672,95521.1
Hodgkin lymphoma4,5742.93,6592.38,2332.6
Non-Hodgkin lymphoma35,48222.429,24015.464,72218.5
Myeloma12,5567.810,0065.122,5626.3
Leukemias26,33716.919,02310.345,36013.2
Acute lymphocytic leukemia2,5991.72,0521.34,6511.5
Chronic lymphocytic leukemia9,2235.85,8693.015,0924.2
Acute myeloid leukemia7,9215.16,4193.514,3404.2
Chronic myeloid leukemia3,4992.32,4951.45,9941.8
Other leukemias3,0952.02,1881.15,2831.5
Mesothelioma2,4411.67660.43,2070.9
Kaposi Sarcoma9850.71200.11,1050.4
Miscellaneous29,23419.026,16113.355,39515.7

Abbreviations: NA = not applicable; NOS = not otherwise specified.
*Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.
§Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population).

Top

Return to your place in the textTABLE 2. Reported number and rate* of cancer deaths, by primary cancer site and sex — United States, 2013
Cancer siteMaleFemaleTotal
No.RateNo.RateNo.Rate
All sites combined307,553196.2277,319139.1584,872163.0
Oral cavity and pharynx6,2273.72,6231.38,8502.4
Lip420170590
Tongue1,5070.97010.42,2080.6
Salivary gland5990.42870.18860.2
Floor of mouth510330840
Gum and other mouth7060.45420.31,2480.3
Nasopharynx4670.31760.16430.2
Tonsil6570.41820.18390.2
Oropharynx6630.42430.19060.2
Hypopharynx2600.26403240.1
Other oral cavity and pharynx1,2750.83780.21,6530.4
Digestive system85,25552.963,52831.4148,78341.1
Esophagus11,7317.12,9581.514,6894.0
Stomach6,7934.34,4682.311,2613.2
Small intestine7050.55650.31,2700.4
Colon and rectum27,23017.324,58312.151,81314.5
Colon excluding rectum21,49413.820,46910.141,96311.7
Rectum and rectosigmoid junction5,7363.54,1142.19,8502.7
Anus, anal canal, and anorectum3710.25290.39000.2
Liver and intrahepatic bile duct16,3009.57,7323.824,0326.5
Gallbladder7500.51,4100.72,1600.6
Other biliary7040.58140.41,5180.4
Pancreas19,85412.419,1429.438,99610.8
Retroperitoneum1110.18201930.1
Peritoneum, omentum, and mesentery7106790.37500.2
Other digestive organs6350.45660.31,2010.3
Respiratory system89,10856.071,53635.9160,64444.6
Nose, nasal cavity, and middle ear2690.21740.14430.1
Larynx2,9941.87350.43,7291.0
Lung and bronchus85,65853.970,51835.4156,17643.4
Pleura420240660
Trachea, mediastinum, and other respiratory organs1450.18502300.1
Bones and joints8320.56210.31,4530.4
Soft tissue including heart2,3781.52,1821.24,5601.3
Skin excluding basal and squamous8,7235.64,0252.012,7483.6
Melanoma of the skin6,2394.03,1551.69,3942.7
Other nonepithelial skin2,4841.68700.43,3540.9
Male and female breastNANANANA41,32411.5
Female breastNANA40,86020.7NANA
Male breast4640.3NANANANA
Female genital systemNANA29,82815.2NANA
CervixNANA4,2172.3NANA
Corpus and uterus, NOSNANA9,3254.6NANA
CorpusNANA3,9031.9NANA
Uterus, NOSNANA5,4222.7NANA
OvaryNANA14,2767.2NANA
VaginaNANA4370.2NANA
VulvaNANA1,0030.5NANA
Other female genital organsNANA5700.3NANA
Male genital system28,39019.7NANANANA
Prostate27,68119.2NANANANA
Testis3830.2NANANANA
Penis2700.2NANANANA
Other male genital organs560NANANANA
Urinary system20,76513.69,7474.830,5128.5
Urinary bladder11,2947.74,4632.115,7574.4
Kidney and renal pelvis8,9675.64,9392.513,9063.9
Ureter2510.21830.14340.1
Other urinary organs2530.21620.14150.1
Eye and orbit1680.11510.13190.1
Brain and other nervous system8,4915.26,8523.615,3434.3
Endocrine system1,3220.81,4570.82,7790.8
Thyroid8380.51,0120.51,8500.5
Other endocrine including thymus4840.34450.39290.3
Lymphomas11,8017.89,4024.721,2036.0
Hodgkin lymphoma6330.44570.21,0900.3
Non-Hodgkin lymphoma11,1687.48,9454.420,1135.7
Myeloma6,4074.25,3942.711,8013.3
Leukemias13,6259.19,9245.023,5496.7
Acute lymphocytic leukemia8000.56250.41,4250.4
Chronic lymphocytic leukemia2,7861.91,8710.94,6571.3
Acute myeloid leukemia5,5903.74,1212.19,7112.8
Chronic myeloid leukemia5780.44110.29890.3
Other leukemias3,8712.62,8961.46,7671.9
Mesothelioma1,9111.35860.32,4970.7
Miscellaneous21,64713.818,5839.140,23011.2

Abbreviations: NA = not applicable; NOS = not otherwise specified.
*Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Data are from the National Vital Statistics System (NVSS).

Top

Return to your place in the textTABLE 3. Reported number and rate* of invasive cancer cases, all sites combined, by geographic division and area — United States, 2013§
Area/StateAll races/ethnicities
No.Rate
Northeast319,548478.5
New England82,466464.8
Connecticut20,510474.2
Maine8,366463.8
Massachusetts36,097457.5
New Hampshire7,886479.2
Rhode Island6,097479.4
Vermont3,510437.1
Middle Atlantic237,082483.5
New Jersey49,960483.1
New York109,560484.3
Pennsylvania77,562483.0
Midwest350,820448.1
East North Central242,838448.2
Illinois64,959454.9
Indiana32,372438.8
Michigan52,067440.1
Ohio62,802452.4
Wisconsin30,638451.1
West North Central107,982447.7
Iowa16,911456.1
Kansas14,572450.9
Minnesota27,770451.8
Missouri31,628442.6
Nebraska9,176437.6
North Dakota3,508433.6
South Dakota4,417450.1
South578,843433.6
South Atlantic316,742432.0
Delaware5,681502.0
District of Columbia2,780445.2
Florida108,216413.0
Georgia45,984450.3
Maryland29,824451.0
North Carolina49,970445.4
South Carolina24,809436.9
Virginia38,151418.5
West Virginia11,327464.0
East South Central101,032464.8
Alabama25,340444.0
Kentucky26,068511.7
Mississippi15,482459.9
Tennessee34,142450.9
West South Central161,069419.0
Arkansas15,879454.0
Louisiana24,184476.3
Oklahoma19,044440.3
Texas101,962399.4
West
Mountain
Arizona28,418370.6
Colorado21,764396.1
Idaho7,358419.5
Montana5,610437.0
Nevada
New Mexico8,728363.7
Utah9,626393.2
Wyoming2,517382.0
Pacific225,898412.3
Alaska2,664410.4
California160,911402.8
Hawaii7,000419.8
Oregon20,458431.5
Washington34,865450.3

*Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population).
Rates and counts are not presented for the West Census Region, the Mountain Census Division, or Nevada because data from Nevada are not included in this analysis.

Top

Return to your place in the textTABLE 4. Reported cancer deaths and death rates,* all sites combined, by geographic division and area — United States, 2013
Area/StateAll races/ethnicities
No.Rate
United States584,872163.0
Northeast109,494160.1
New England28,932159.4
Connecticut6,619147.8
Maine3,227174.8
Massachusetts12,858159.7
New Hampshire2,584158.6
Rhode Island2,326173.9
Vermont1,318164.1
Middle Atlantic80,562160.4
New Jersey16,315156.0
New York35,735155.5
Pennsylvania28,512170.0
Midwest135,293170.7
East North Central94,527173.0
Illinois24,491171.7
Indiana13,258179.4
Michigan20,367170.2
Ohio24,986177.4
Wisconsin11,425164.6
West North Central40,766165.6
Iowa6,509168.2
Kansas5,379162.9
Minnesota9,601155.1
Missouri12,955179.1
Nebraska3,459160.7
North Dakota1,286150.8
South Dakota1,577154.1
South223,673168.4
South Atlantic120,225162.8
Delaware1,905167.1
District of Columbia1,095177.7
Florida42,734154.9
Georgia16,417168.1
Maryland10,608163.0
North Carolina18,589167.7
South Carolina9,745174.0
Virginia14,414162.3
West Virginia4,718190.5
East South Central40,890189.5
Alabama10,328182.1
Kentucky10,082199.3
Mississippi6,527196.5
Tennessee13,953185.4
West South Central62,558167.3
Arkansas6,688189.6
Louisiana9,419188.7
Oklahoma8,039185.4
Texas38,412156.9
West116,412148.3
Mountain35,623146.1
Arizona11,347146.4
Colorado7,357139.2
Idaho2,707156.3
Montana1,997154.0
Nevada4,817164.9
New Mexico3,481145.1
Utah2,971127.9
Wyoming946147.7
Pacific80,789149.3
Alaska1,016173.1
California57,714146.6
Hawaii2,332134.9
Oregon7,799163.2
Washington11,928156.3

*Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Data are from the National Vital Statistics System (NVSS).

Top

Return to your place in the textTABLE 5. Reported number and rate* of invasive cancer cases, by primary cancer site and age group — United States, 2013§
Cancer siteAge group (yrs)Total (all ages)
<1515–2425–3940–64≥65
No.RateNo.RateNo.RateNo.RateNo.RateNo.Rate (crude)
All sites combined10,17216.812,48228.659,28095.7625,691606.5851,5051,920.31,559,130497.0
Oral cavity and pharynx1070.22260.51,1381.821,69921.018,54741.841,71713.3
Esophagus1310.26,5136.39,78222.116,4325.2
Stomach670.26391.08,3018.014,13731.97.4
Colon and rectum480.13590.83,4635.652,99451.479,255178.7136,11943.4
Liver and intrahepatic bile duct1800.3760.23070.515,10414.613,80631.129,4739.4
Pancreas570.14460.714,50614.129,36166.214.1
Larynx930.25,9985.86,33714.312,4424.0
Lung and bronchus350.11010.29481.565,46263.5146,038329.3212,58467.8
Melanomas of the skin1200.29122.15,4778.829,69828.835,73680.671,94322.9
Female breast1890.99,96532.3117,033222.1103,622415.9144.8
Cervix1200.62,7969.16,60512.52,4289.77.5
Corpus and uterus, NOS620.31,6075.226,84451.022,04488.531.7
Ovary1150.43461.61,0283.39,49818.09,94039.920,92713.1
Prostate940.374,866148.3101,478522.4176,450114.3
Testis690.21,4646.54,22213.62,3964.72001.08,3515.4
Urinary bladder200550.15130.817,78717.252,576118.670,95122.6
Kidney and renal pelvis5490.91610.42,1403.525,80925.028,28963.856,94818.2
Brain and nervous system2,1703.69542.22,0233.38,3818.18,32018.821,8487.0
Thyroid2220.41,9364.49,82015.825,47724.710,23823.147,69315.2
Hodgkin lymphoma3270.51,5163.52,1833.52,6312.61,5763.68,2332.6
Non-Hodgkin lymphoma5911.09232.12,9094.723,04622.337,25384.064,72220.6
Myeloma2780.47,9537.714,31332.322,5627.2
Leukemias2,8964.81,2412.82,1623.513,92213.525,13956.745,36014.5
Mesothelioma460.16760.72,4785.63,2071.0
Kaposi Sarcoma430.13000.54600.43010.70.4

Abbreviation: NOS = not otherwise specified.
*Rates are the number of cases per 100,000 persons. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.
§Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population).
Counts and rates are suppressed if <16 cases were reported in a specific category. Some counts and rates are suppressed as complementary cell suppression.

Top

Return to your place in the textTABLE 6. Reported number and rate* of cancer deaths, by primary cancer site and age group — United States, 2013
Cancer siteAge group (yrs)Total (all ages)
<1515–2425–3940–64≥65
No.RateNo.RateNo.RateNo.RateNo.RateNo.Rate (crude)
All sites combined1,2872.11,4963.47,44611.9167,085160.5407,558911.3584,872184.8
Oral cavity and pharynx§1140.23,6083.55,11111.48,8502.8
Esophagus870.15,1615.09,44121.114,6894.6
Stomach1902870.53,5043.47,45016.73.6
Colon and rectum460.18051.315,35614.835,60379.616.4
Liver and intrahepatic bile duct330.1320.12110.310,0899.713,66730.624,0327.6
Pancreas1830.310,75610.328,04562.738,99612.3
Larynx1,3501.32,3725.33,7291.2
Lung and bronchus2203830.642,73341.1113,032252.749.3
Melanomas of the skin260.13520.63,0823.05,93213.33.0
Female breast9613.115,77429.724,11496.040,86025.4
Cervix4221.42,3694.51,4135.64,2172.6
Corpus and uterus, NOS1060.33,0245.76,19424.79,3255.8
Ovary320.11700.54,6148.79,45837.78.9
Prostate3,0336.024,638125.727,68117.8
Testis320.11300.41670.3530.30.2
Urinary bladder3102,4502.413,27529.715,7575.0
Kidney and renal pelvis400.11901380.24,2564.19,45321.113,9064.4
Brain and nervous system4370.72410.57511.26,0805.87,83417.515,3434.8
Thyroid1704730.51,3573.01,8500.6
Hodgkin lymphoma320.11370.23340.35831.30.3
Non-Hodgkin lymphoma290910.23440.54,0893.915,56034.820,1136.4
Myeloma330.12,4782.49,28920.811,8013.7
Leukemias3500.63450.86431.04,5744.417,63739.423,5497.4
Mesothelioma4430.42,0454.62,4970.8

Abbreviation: NOS = not otherwise specified.
*Rates are the number of deaths per 100,000 persons. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Data are from the National Vital Statistics System (NVSS).
§Counts and rates are suppressed if <16 cases were reported in a specific category. Some counts and rates are suppressed as complementary cell suppression.

Top

Return to your place in the textTABLE 7. Reported number and rate* of invasive cancer cases, by primary cancer site and race§ — United States, 2013
Cancer siteAI/ANA/PIBlackWhite
No.RateNo.RateNo.RateNo.Rate
All sites combined8,676276.447,802284.0170,123443.61,304,263439.3
Oral cavity and pharynx2447.11,3737.83,6449.035,85811.8
Lip—**180.1260.11,8160.6
Tongue691.93021.88132.011,4023.7
Salivary gland170.51861.14231.13,7101.3
Floor of mouth360.22210.51,6930.5
Gum and other mouth240.82161.35021.34,5901.5
Nasopharynx160.54112.22680.71,0900.4
Tonsil461.21140.66321.57,0732.3
Oropharynx170.5190.12670.61,5900.5
Hypopharynx190.5600.43620.91,8890.6
Other oral cavity and pharynx1300.31,0050.3
Digestive system1,91963.311,41670.135,83594.9227,26775.5
Esophagus933.23262.01,6044.214,2894.7
Stomach2026.91,69410.73,5639.917,3385.8
Small intestine331.01841.11,4063.76,4822.2
Colon and rectum90529.94,92129.616,84344.9111,62337.5
Colon excluding rectum59720.63,13819.312,37933.579,69526.8
Rectum and rectosigmoid junction3089.31,78310.34,46411.431,92810.8
Anus, anal canal, and anorectum330.9840.57291.85,6611.9
Liver and intrahepatic bile duct3129.32,03712.34,42210.422,3507.1
Gallbladder431.71961.26261.83,0191.0
Other biliary361.33432.26041.75,3311.8
Pancreas2217.71,4339.25,49215.136,90812.1
Retroperitoneum590.31460.41,0110.4
Peritoneum, omentum, and mesentery170.5620.41640.41,7200.6
Other digestive organs180.6770.52360.71,5350.5
Respiratory system1,25143.85,75636.824,48866.2195,29764.4
Nose, nasal cavity, and middle ear940.62520.61,9300.7
Larynx581.81771.11,6724.210,4023.4
Lung and bronchus1,17541.55,44635.022,48961.2182,35260.1
Pleura920
Trachea, mediastinum, and other respiratory organs370.2680.25210.2
Bones and joints270.7990.53330.82,4661.0
Soft tissue including heart802.44142.41,2833.39,0583.2
Skin excluding basal and squamous1926.13231.97462.072,41725.1
Melanomas of the skin1615.02131.33621.067,29123.3
Other nonepithelial skin311.11100.73841.05,1261.8
Male and female breast1,27938.68,94649.927,16070.1192,81766.0
Female breast1,27272.38,91491.126,854122.9191,077124.4
Male breast320.43061.91,7401.3
Female genital system62434.23,52935.810,26746.776,11249.1
Cervix1186.35885.91,9369.09,0587.0
Corpus and uterus, NOS31917.31,84818.55,54624.842,11626.2
Corpus30916.71,79618.05,18523.240,94625.4
Uterus, NOS520.53611.61,1700.7
Ovary1458.18879.21,9699.117,68811.4
Vagina400.41890.91,0170.6
Vulva251.6730.83951.84,3242.7
Other female genital organs930.92321.11,9091.2
Male genital system85558.34,07955.028,677166.9145,637100.1
Prostate76254.03,85352.528,208164.4136,60492.5
Testis803.31781.82851.47,5986.4
Penis260.41440.91,1330.9
Other male genital organs220.3400.23020.2
Urinary system74624.32,61816.411,08829.7114,60638.3
Urinary bladder2328.71,2478.34,04011.664,23621.3
Kidney and renal pelvis50015.01,2747.56,86417.647,63016.1
Ureter650.4710.21,7490.6
Other urinary organs320.21130.39910.3
Eye and orbit560.31120.32,5370.9
Brain and other nervous system1123.06223.61,6394.019,2117.0
Brain1042.85663.31,4873.718,0966.5
Cranial nerves other nervous system560.31520.41,1150.4
Endocrine system3158.32,94415.74,14010.241,56315.8
Thyroid2987.82,79614.93,7599.339,75815.1
Other endocrine including thymus170.51480.93810.91,8050.7
Lymphomas34510.92,26213.66,40816.462,52521.6
Hodgkin lymphoma371.02161.11,1092.66,6882.6
Non-Hodgkin lymphoma3089.92,04612.45,29913.855,83719.0
Myeloma1244.35953.74,65912.816,8455.6
Leukemias2347.31,2067.13,81110.139,00613.6
Acute lymphocytic leukemia410.92051.13850.93,8961.6
Chronic lymphocytic leukemia491.81440.91,1153.113,2294.3
Acute myeloid leukemia802.65393.21,2683.412,3074.3
Chronic myeloid leukemia310.91831.05991.55,0131.8
Other leukemias331.21350.84441.24,5611.6
Mesothelioma460.31460.42,9821.0
Kaposi Sarcoma290.22920.76950.3
Miscellaneous29810.71,4899.85,39515.247,36415.8

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander; NOS = not otherwise specified.
*Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.
§Rates are not presented for persons of unknown or other race; therefore, categories do not sum to total. Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).
**Counts and rates are suppressed if <16 cases were reported.

Top

Return to your place in the textTABLE 8. Reported number and rate* of cancer deaths, by primary site and race— United States, 2013§
Cancer siteAI/ANA/IBlackWhite
No.RateNo.RateNo.RateNo.Rate
All sites combined3,109111.215,703100.067,952189.5498,108163.3
Oral cavity and pharynx321.03141.91,0762.87,4282.4
Lip550
Tongue530.32030.51,9450.6
Salivary gland220.1750.27880.3
Floor of mouth740
Gum and other mouth460.31220.31,0770.3
Nasopharynx1270.7950.24160.1
Tonsil860.27360.2
Oropharynx180.11390.47460.2
Hypopharynx700.22460.1
Other oral cavity and pharynx280.22750.71,3450.4
Digestive system1,02035.35,60835.519,24053.0122,91540.0
Esophagus742.62711.71,3083.513,0364.2
Stomach963.58085.11,9645.68,3932.8
Small intestine290.22190.61,0170.3
Colon and rectum35112.61,5579.76,85419.343,05114.1
Colon excluding rectum27110.01,2157.75,77216.334,70511.4
Rectum and rectosigmoid junction802.63422.11,0823.08,3462.7
Anus, anal canal, and anorectum220.11040.37690.3
Liver and intrahepatic bile duct2568.01,5429.53,3858.418,8496.0
Gallbladder190.81200.83290.91,6920.6
Other biliary580.41370.41,3130.4
Pancreas1886.81,1247.54,73713.432,94710.7
Retroperitoneum200.11610.1
Peritoneum, omentum, and mesentery190.1480.16790.2
Other digestive organs460.31350.41,0080.3
Respiratory system77728.83,62223.817,58448.8138,66145.3
Nose, nasal cavity, and middle ear200.1410.13800.1
Larynx190.6530.35991.63,0581.0
Lung and bronchus75428.03,53923.316,90646.9134,97744.1
Pleura600
Trachea, mediastinum, and other respiratory organs350.11860.1
Bones and joints410.21640.41,2380.4
Soft tissue including heart300.91560.95521.43,8221.3
Skin excluding basal and squamous301.0810.53060.812,3314.1
Melanomas of the skin160.5460.31410.49,1913.1
Other nonepithelial skin350.21650.43,1401.0
Male and female breast1665.51,0596.26,16716.633,93211.2
Female breast16610.11,04811.06,08628.233,56020.3
Male breast600.43400.3
Female genital system1489.08999.64,03519.024,74615.0
Cervix301.71871.98383.93,1622.2
Corpus and uterus, NOS372.22632.81,7648.37,2614.3
Corpus161.0971.06823.23,1081.8
Uterus, NOS211.31661.81,0825.14,1532.5
Ovary734.54164.51,2546.012,5337.5
Vagina540.33730.2
Vulva640.39240.5
Other female genital organs610.34930.3
Male genital system13814.54928.94,59439.523,16618.4
Prostate13114.24738.64,52839.122,54918.0
Testis3540.3
Penis420.32180.2
Other male genital organs450
Urinary system1676.15503.72,4807.227,3158.9
Urinary bladder481.72481.81,1673.514,2944.7
Kidney and renal pelvis1184.32721.71,2603.512,2564.0
Ureter210.1180.13940.1
Other urinary organs350.13710.1
Eye and orbit3100.1
Brain and other nervous system682.13762.29412.413,9584.7
Endocrine system200.71410.93080.92,3100.8
Thyroid170.6980.71820.51,5530.5
Other endocrine including thymus430.21260.37570.3
Lymphomas913.56084.01,5684.418,9366.3
Hodgkin lymphoma210.11080.39580.3
Non-Hodgkin lymphoma883.45873.91,4604.117,9785.9
Myeloma632.32141.42,1576.49,3673.1
Leukemias1043.75803.71,9875.720,8787.0
Acute lymphocytic leukemia530.31360.31,2210.5
Chronic lymphocytic leukemia330.23781.14,2361.4
Acute myeloid leukemia481.73172.07782.28,5682.9
Chronic myeloid leukemia220.1990.38610.3
Other leukemias241.01551.05961.75,9922.0
Mesothelioma350.21120.32,3420.8
Miscellaneous2378.79256.04,66713.034,40111.2

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander; NOS = not otherwise specified.
*Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).
§Data are from the National Vital Statistics System (NVSS).
Counts and rates are suppressed if <16 cases were reported.

Top

Return to your place in the textTABLE 9. Reported number and rate* of invasive cancer cases, by primary cancer site and ethnicity§ — United States, 2013
Cancer siteHispanicNon-Hispanic
No.RateNo.Rate
All sites combined117,332343.71,403,357450.8
Oral cavity and pharynx2,3606.838,27912.1
Lip890.31,8110.6
Tongue6531.911,7973.7
Salivary gland2980.83,9861.3
Floor of mouth990.31,8360.6
Gum and other mouth3461.14,9421.6
Nasopharynx1520.41,6070.5
Tonsil4381.27,3172.3
Oropharynx980.31,7530.5
Hypopharynx1340.42,1330.7
Other oral cavity and pharynx530.21,0970.3
Digestive system25,40179.0247,67378.5
Esophagus8002.615,2284.7
Stomach3,1299.819,4556.2
Small intestine5901.87,3792.4
Colon and rectum10,99733.8121,90739.1
Colon excluding rectum7,56223.987,06627.9
Rectum and rectosigmoid junction3,43510.034,84111.2
Anus, anal canal, and anorectum4401.35,9771.9
Liver and intrahepatic bile duct4,31112.924,5457.4
Gallbladder5861.93,2441.0
Other biliary7352.55,5241.7
Pancreas3,35711.139,91012.5
Retroperitoneum1410.41,0550.4
Peritoneum, omentum, and mesentery1300.41,7980.6
Other digestive organs1850.61,6510.5
Respiratory system10,26134.9212,14966.6
Nose, nasal cavity, and middle ear2340.72,0360.7
Larynx8092.511,3103.5
Lung and bronchus9,12531.5198,16262.2
Pleura—**880
Trachea, mediastinum, and other respiratory organs800.25530.2
Bones and joints4240.92,4870.9
Soft tissue including heart1,2103.09,5713.3
Skin excluding basal and squamous1,8425.374,08624.6
Melanomas of the skin1,5354.468,54322.8
Other nonepithelial skin3070.95,5431.8
Male and female breast18,15550.1208,42568.3
Female breast18,04193.4206,497127.4
Male breast1140.81,9281.3
Female genital system9,03445.480,63749.0
Cervix2,0109.39,6897.0
Corpus and uterus, NOS4,51723.144,80026.1
Corpus4,30121.943,44425.3
Uterus, NOS2161.21,3560.8
Ovary1,9129.718,50711.3
Vagina1290.71,1000.6
Vulva2951.74,4922.7
Other female genital organs1710.92,0491.2
Male genital system14,00893.6167,698110.0
Prostate12,40387.5159,452103.2
Testis1,4004.76,7825.7
Penis1841.21,1160.8
Other male genital organs210.13480.3
Urinary system8,92627.7119,09838.0
Urinary bladder3,13511.066,22220.9
Kidney and renal pelvis5,63416.150,00616.1
Ureter960.41,7600.6
Other urinary organs610.21,1100.4
Eye and orbit2160.52,5480.9
Brain and other nervous system2,1475.219,1936.7
Brain1,9664.818,0496.3
Cranial nerves other nervous system1810.41,1440.4
Endocrine system5,96513.842,87715.7
Thyroid5,70013.240,80114.9
Other endocrine including thymus2650.62,0760.8
Lymphomas6,77519.264,39621.4
Hodgkin lymphoma1,0842.46,9342.7
Non-Hodgkin lymphoma5,69116.957,46218.7
Myeloma1,9086.120,1286.4
Leukemias4,24310.740,18513.4
Acute lymphocytic leukemia1,2172.13,3611.4
Chronic lymphocytic leukemia6212.114,1884.4
Acute myeloid leukemia1,3213.612,6904.2
Chronic myeloid leukemia5971.55,2601.8
Other leukemias4871.44,6861.6
Mesothelioma2220.72,8950.9
Kaposi Sarcoma2440.68440.3
Miscellaneous3,99113.250,18816.0

Abbreviation: NOS = not otherwise specified.
*Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.
§Rates and counts are not presented for persons of unknown ethnicity; therefore, categories do not sum to total. Data for specified ethnic populations should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).
Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined and have information on ethnicity (all registries except Nevada and Virginia, covering approximately 97% of the U.S. population). Data from Nevada did not meet the data quality criteria and information about ethnicity was missing on 85% of the cases from Virginia.
**Counts and rates are suppressed if <16 cases were reported. Some counts and rates are suppressed as complementary cell suppression.

Top

Return to your place in the textTABLE 10. Reported number and rate* of cancer deaths, by primary cancer site and ethnicity — United States, 2013§
Cancer siteHispanicNon-Hispanic
No.RateNo.Rate
All sites combined35,147114.7548,516167.2
Oral cavity and pharynx4551.48,3642.5
Lip580
Tongue1140.32,0860.6
Salivary gland390.18450.3
Floor of mouth810
Gum and other mouth650.21,1780.4
Nasopharynx370.16050.2
Tonsil380.17980.2
Oropharynx580.28430.3
Hypopharynx230.12980.1
Other oral cavity and pharynx770.21,5720.5
Digestive system11,91438.7136,55141.3
Esophagus5931.914,0604.2
Stomach1,6335.19,6053.0
Small intestine780.31,1900.4
Colon and rectum3,56811.748,13314.7
Colon excluding rectum2,9029.638,97311.9
Rectum and rectosigmoid junction6662.09,1602.8
Anus, anal canal, and anorectum500.18460.3
Liver and intrahepatic bile duct2,9949.320,9746.2
Gallbladder2540.91,9050.6
Other biliary1230.41,3930.4
Pancreas2,4738.436,45811.0
Retroperitoneum190.11740.1
Peritoneum, omentum, and mesentery400.17060.2
Other digestive organs890.31,1070.3
Respiratory system5,62919.7154,68046.8
Nose, nasal cavity, and middle ear330.14080.1
Larynx2190.73,4981.0
Lung and bronchus5,35318.8150,50245.6
Pleura620
Trachea, mediastinum, and other respiratory organs200.12100.1
Bones and joints1880.51,2610.4
Soft tissue including heart3921.04,1611.3
Skin excluding basal and squamous3571.212,3723.8
Melanomas of the skin2360.79,1512.9
Other nonepithelial skin1210.43,2211.0
Male and female breast2,6958.038,54011.8
Female breast2,67114.538,10421.3
Male breast240.24360.3
Female genital system2,28012.627,49215.4
Cervix5212.53,6822.3
Corpus and uterus, NOS6793.88,6294.7
Corpus2221.23,6732.0
Uterus, NOS4572.64,9562.7
Ovary9425.313,3127.4
Vagina390.23980.2
Vulva630.49390.5
Other female genital organs360.25320.3
Male genital system1,75816.326,56719.9
Prostate1,63415.825,98319.4
Testis800.33020.2
Penis410.22290.2
Other male genital organs530
Urinary system1,7205.928,7308.7
Urinary bladder6302.415,0984.6
Kidney and renal pelvis1,0533.412,8203.9
Ureter180.14160.1
Other urinary organs190.13960.1
Eye and orbit170.13020.1
Brain and other nervous system1,0462.914,2794.5
Endocrine system2750.82,4980.8
Thyroid1770.61,6700.5
Other endocrine including thymus980.28280.3
Lymphomas1,5935.319,5716.1
Hodgkin lymphoma1340.49540.3
Non-Hodgkin lymphoma1,4594.918,6175.7
Myeloma7742.711,0033.4
Leukemias1,6775.121,8336.8
Acute lymphocytic leukemia3200.71,1030.4
Chronic lymphocytic leukemia1460.64,5021.4
Acute myeloid leukemia6662.09,0322.8
Chronic myeloid leukemia700.29160.3
Other leukemias4751.66,2802.0
Mesothelioma1250.42,3690.7
Miscellaneous2,2387.537,89811.5

Abbreviation: NOS = not otherwise specified.
*Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Data are from the National Vital Statistics System (NVSS).
§Rates are not presented for persons of unknown ethnicity; therefore, categories do not sum to total. Data for specified ethnic populations should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).
Counts and rates are suppressed if <16 cases were reported.

Top

Return to your place in the textFIGURE 1. Age-adjusted rate* of invasive cancer cases for most common sites, by sex and race/ethnicity§ — United States, 2013

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander.

Sources: CDC’s National Program of Cancer Registries and National Cancer Institute’s Surveillance, Epidemiology, and End Results program.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.

§ Race categories are not mutually exclusive from Hispanic origin. The Hispanic category excludes any cases from Virginia because information about ethnicity was missing on 85% of cases. Rates are not presented for persons of unknown or other race. Data for specified racial or ethnic populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population). Caution should be used when comparing incidence and death rates because of the difference in population coverage.

Top

Return to your place in the textFIGURE 2. Age-adjusted rate* of cancer deaths for most common sites, by sex and race/ethnicity — United States, 2013§

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

Data are from the National Vital Statistics System (NVSS). Data for death rates cover 100% of the U.S. population. Use caution when comparing incidence and death rates because of potential differences in population coverage.

§ Race categories are not mutually exclusive from Hispanic origin. Rates are not presented for persons of unknown or other race. Data for specified racial or ethnic populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

Top

Return to your place in the textFIGURE 3. Age-adjusted rate* of invasive cancer cases, by primary cancer site and state — United States, 2013§

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). Rates are presented by quartiles. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.

§ Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population).

Top

Return to your place in the textFIGURE 4. Age-adjusted rate* of cancer deaths, by primary cancer site and state — United States, 2013

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). Rates are presented by quartiles. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria).

Data are from the National Vital Statistics System (NVSS). Data for death rates cover 100% of the U.S. population. Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Top

Return to your place in the textTABLE 11. Reported number of invasive* cancer cases, all cancer sites combined, by state — United States, 2004–2013
State 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Alaska 2,430 2,371 2,496 2,513 2,671 2,647 2,746 2,666 2,612 2,664
Alabama 22,251 22,665 23,351 24,215 25,316 25,307 25,305 25,195 25,383 25,340
Arkansas 13,918 14,203 14,417 14,871 14,833 14,984 15,190 15,151 15,512 15,879
Arizona 24,196 24,629 25,784 27,018 26,803 28,295 27,622 28,743 28,545 28,418
California 146,314 148,143 149,651 156,072 158,341 160,282 161,351 161,217 160,817 160,911
Colorado 18,345 18,882 19,261 20,696 20,948 21,627 21,448 21,761 21,846 21,764
Connecticut 19,474 19,775 20,534 20,587 20,692 21,069 20,773 20,665 20,592 20,510
District of Columbia 2,742 2,765 2,751 2,972 2,728 2,807 2,939 3,135 3,003 2,780
Delaware 4,495 4,799 5,058 5,141 5,239 5,277 5,281 5,466 5,459 5,681
Florida 101,494 104,701 105,486 107,733 110,183 109,603 108,931 110,653 109,554 108,216
Georgia 36,724 37,382 39,182 42,013 42,977 43,660 43,118 44,921 46,154 45,984
Hawaii 6,013 6,103 6,194 6,406 6,640 6,773 6,730 6,788 6,852 7,000
Idaho 6,170 6,573 6,766 7,171 7,148 7,366 7,431 7,551 7,538 7,358
Illinois 61,518 61,898 63,773 64,956 66,301 66,557 65,198 66,369 65,130 64,959
Indiana 30,156 30,659 31,712 32,023 32,417 32,423 32,677 32,864 32,543 32,372
Iowa 16,254 16,457 16,744 16,852 16,944 17,594 17,526 17,531 17,175 16,911
Kansas 13,644 13,695 14,003 14,553 14,727 14,608 14,608 14,906 14,843 14,572
Kentucky 22,498 22,774 23,960 24,527 24,697 24,919 25,484 25,669 26,191 26,068
Louisiana 22,071 21,076 21,575 22,431 22,906 23,560 23,661 24,150 24,198 24,184
Massachusetts 35,459 35,919 37,105 37,201 37,736 37,478 35,711 37,198 36,481 36,097
Maryland 25,491 25,865 26,002 27,907 28,447 28,463 28,710 28,642 28,489 29,824
Maine 8,347 8,305 8,628 8,542 8,472 8,356 8,385 8,336 8,481 8,366
Michigan 52,128 52,819 53,501 55,831 53,580 54,009 55,167 55,617 53,248 52,067
Minnesota 24,502 24,622 25,505 26,801 26,990 26,901 27,028 28,019 27,835 27,770
Missouri 28,895 30,601 30,832 31,108 31,042 31,893 31,203 31,901 32,136 31,628
Mississippi 13,506 13,663 14,235 15,005 15,328 15,033 15,460 15,361 15,343 15,482
Montana 4,914 5,225 5,192 5,350 5,369 5,612 5,627 5,722 5,517 5,610
North Carolina 41,513 43,778 44,991 46,870 47,706 49,465 49,546 50,395 49,248 49,970
North Dakota 3,327 3,477 3,497 3,594 3,525 3,485 3,585 3,724 3,694 3,508
Nebraska 8,807 9,031 9,171 9,398 9,216 8,851 9,158 9,204 9,018 9,176
Nevada §
New Hampshire 7,002 7,233 7,280 7,448 7,714 7,618 7,742 7,971 7,745 7,886
New Jersey 46,552 46,971 48,590 49,194 49,083 49,495 48,838 49,687 49,268 49,960
New Mexico 8,247 8,272 8,486 8,775 8,984 9,021 9,006 8,851 8,815 8,728
New York 100,219 101,660 104,618 106,397 108,138 108,711 106,341 110,138 106,911 109,560
Ohio 58,765 60,115 60,763 61,490 63,211 62,975 61,175 62,348 60,801 62,802
Oklahoma 17,758 17,875 18,960 19,744 18,857 18,957 18,637 18,897 19,082 19,044
Oregon 18,499 18,682 19,112 19,376 20,370 19,909 19,727 20,636 20,035 20,458
Pennsylvania 73,045 73,803 75,923 77,186 77,243 77,601 77,931 79,562 76,689 77,562
Rhode Island 6,289 6,001 6,270 6,358 6,269 6,239 5,762 5,898 6,168 6,097
South Carolina 21,118 21,933 22,555 23,504 23,576 23,883 24,638 24,737 25,399 24,809
South Dakota 4,021 3,922 3,830 4,079 4,029 4,191 4,126 4,429 4,225 4,417
Tennessee 27,702 30,218 30,998 32,100 32,957 34,014 33,854 34,374 34,363 34,142
Texas 90,532 92,394 94,362 98,911 99,603 100,782 99,386 100,351 101,919 101,962
Utah 7,763 7,920 8,309 8,517 8,859 9,108 9,496 9,712 9,681 9,626
Virginia 33,484 34,571 35,351 37,244 37,308 37,846 36,402 37,277 36,744 38,151
Vermont 3,387 3,460 3,718 3,602 3,529 3,681 3,659 3,630 3,609 3,510
Washington 30,679 31,403 31,843 31,339 33,240 34,143 34,320 34,869 34,883 34,865
Wisconsin 27,929 27,869 28,645 29,475 29,967 30,174 30,575 31,413 30,572 30,638
West Virginia 10,741 11,071 11,250 11,546 11,296 11,352 11,231 11,638 11,336 11,327

*Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population). Registry-specific data quality information is available at https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria.
§Counts are not presented for Nevada because data from Nevada did not meet USCS publication criteria for all the years from 2004 to 2013.

Top

Return to your place in the textTABLE 12. Reported rate* of invasive cancer cases, all cancer sites combined, by state — United States, 2004–2013§
State 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Alaska 511.2 481.2 486.2 471.6 479.5 460.5 458.7 430.7 404.0 410.4
Alabama 460.6 461.7 464.7 473.4 485.0 477.2 466.6 457.7 453.8 444.0
Arkansas 462.1 465.1 461.3 468.4 457.6 455.2 453.5 445.0 450.1 454.0
Arizona 418.1 408.7 413.1 419.1 405.9 415.7 394.8 399.8 384.7 370.6
California 451.6 448.1 446.1 455.5 451.0 445.6 437.2 425.6 414.0 402.8
Colorado 447.1 447.1 439.7 456.9 447.0 445.2 429.4 423.1 409.8 396.1
Connecticut 507.5 510.0 524.5 518.6 511.4 514.1 499.7 490.4 482.3 474.2
District of Columbia 487.4 487.0 488.7 523.8 477.2 482.2 494.6 516.6 482.4 445.2
Delaware 507.7 525.8 537.5 529.1 526.3 516.6 507.6 511.8 496.7 502.0
Florida 470.9 474.1 469.7 470.9 471.9 460.6 447.8 444.3 428.5 413.0
Georgia 476.6 468.9 473.0 490.3 485.5 480.1 459.5 468.3 465.0 450.3
Hawaii 435.2 430.2 427.4 434.2 438.7 438.9 425.6 421.8 418.1 419.8
Idaho 463.1 478.0 473.0 484.4 467.3 467.6 458.0 454.4 442.2 419.5
Illinois 492.8 490.0 500.1 501.6 503.5 497.8 479.9 480.8 463.8 454.9
Indiana 476.4 477.3 485.4 481.5 477.4 469.5 465.4 460.3 448.8 438.8
Iowa 485.3 487.6 490.4 487.7 485.1 497.0 489.5 484.4 468.0 456.1
Kansas 481.1 477.7 481.9 493.6 492.0 479.4 473.5 477.6 467.4 450.9
Kentucky 521.9 518.1 533.8 535.1 528.3 523.3 526.4 521.6 522.1 511.7
Louisiana 497.0 481.1 493.8 501.1 500.3 502.0 495.4 494.5 485.8 476.3
Massachusetts 514.3 517.0 529.8 523.3 522.0 509.5 477.9 489.3 471.9 457.5
Maryland 463.9 463.1 458.1 482.3 482.3 469.1 465.4 452.3 440.2 451.0
Maine 544.7 534.0 544.8 527.8 512.8 499.1 493.4 484.0 478.7 463.8
Michigan 504.2 504.5 504.2 517.1 489.8 485.8 489.1 485.1 456.8 440.1
Minnesota 481.2 475.7 483.3 496.5 488.5 476.9 471.3 477.7 462.8 451.8
Missouri 470.3 490.5 485.7 481.5 471.8 476.2 458.4 462.2 457.6 442.6
Mississippi 468.1 469.2 479.5 495.1 498.4 482.2 485.8 474.6 465.3 459.9
Montana 473.6 492.2 478.2 475.6 467.3 476.9 472.2 468.8 442.1 437.0
North Carolina 478.1 490.3 486.6 490.2 483.8 489.3 477.6 473.3 450.8 445.4
North Dakota 462.9 479.8 475.8 485.2 467.5 458.7 462.9 470.0 464.0 433.6
Nebraska 479.3 485.0 485.9 490.7 473.6 449.0 456.4 453.8 435.7 437.6
Nevada
New Hampshire 523.9 530.6 519.3 517.8 524.6 506.3 502.0 510.8 484.6 479.2
New Jersey 508.9 509.4 522.0 521.7 512.8 509.6 494.6 496.9 484.4 483.1
New Mexico 431.0 420.4 416.5 419.0 418.8 409.4 397.0 381.7 374.7 363.7
New York 496.2 499.5 511.0 513.1 514.8 510.0 492.1 501.2 479.8 484.3
Ohio 479.4 485.3 484.3 482.5 488.6 480.8 459.7 463.0 444.8 452.4
Oklahoma 477.6 475.0 494.7 505.9 474.8 467.8 452.4 451.5 449.5 440.3
Oregon 484.8 477.6 475.0 470.6 482.3 461.5 447.5 458.1 432.5 431.5
Pennsylvania 502.5 503.9 512.8 515.2 509.9 506.8 502.8 507.5 482.9 483.0
Rhode Island 530.8 508.5 526.6 532.4 519.1 512.6 468.7 476.6 488.9 479.4
South Carolina 484.2 490.4 485.8 489.0 475.0 469.2 472.1 463.4 459.8 436.9
South Dakota 476.5 459.9 440.3 460.9 448.2 459.6 443.2 467.5 439.6 450.1
Tennessee 449.7 479.2 478.8 483.3 484.0 489.9 476.6 472.9 463.6 450.9
Texas 467.9 464.3 457.7 465.3 454.4 445.8 427.3 417.6 411.5 399.4
Utah 426.4 419.7 423.4 419.2 421.7 419.9 424.5 422.9 408.4 393.2
Virginia 455.7 458.8 458.9 471.4 462.0 457.4 428.8 429.3 414.0 418.5
Vermont 499.5 501.2 529.0 501.3 479.1 492.8 481.0 469.9 457.0 437.1
Washington 505.3 504.3 496.9 475.4 491.6 490.1 479.6 476.3 463.3 450.3
Wisconsin 480.8 472.5 478.5 483.4 482.4 477.8 476.5 479.3 457.7 451.1
West Virginia 491.8 501.2 503.1 507.9 491.5 488.1 477.7 489.7 470.7 464.0
Wyoming 451.2 427.5 454.2 436.1 438.1 426.5 432.9 437.2 398.0 382.0

*Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population). Registry-specific data quality information is available at https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria.
Rates are not presented for Nevada because data from Nevada did not meet USCS publication criteria for all the years from 2004 to 2013.

Top

Return to your place in the textFIGURE 5. Age-adjusted rate* of invasive cancer cases, by primary cancer site, race,§ and sex — United States, 1999–2013

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.

§ Rates are not presented for persons of unknown or other race. Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined for all years, 1999–2013 (all registries except Arkansas, District of Columbia, Mississippi, Nevada, South Dakota, Tennessee, and Virginia, covering approximately 92% of the U.S. population). See registry-specific data quality information for all years, 1999–2013 (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria). Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Top

Return to your place in the textFIGURE 6. Age-adjusted rate* of invasive cancer cases, by primary cancer site, ethnicity,§ and sex — United States, 1999–2013

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes(https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.

§ Rates are not presented for persons of unknown ethnicity. Data for specified ethnical populations should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined for all years, 1999–2013 (all registries except Arkansas, District of Columbia, Mississippi, Nevada, South Dakota, Tennessee, and Virginia, covering approximately 92% of the U.S. population). See registry-specific data quality information for all years, 1999–2013 (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria). Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Top

Return to your place in the textFIGURE 7. Age-adjusted rate* of cancer deaths, by primary cancer site, race, and sex — United States, 2013§

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander.

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

Rates are not presented for persons of unknown or other race. Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

§ Data are from the National Vital Statistics System (NVSS). Data for death rates cover 100% of the U.S. population. Use caution when comparing incidence and death rates because of potential differences in population coverage.

Top

Return to your place in the textFIGURE 8. Reported rate* of cancer deaths, by primary cancer site, ethnicity, and sex — United States, 2013§

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

Rates are not presented for persons of unknown ethnicity. Data for specified ethnic populations should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

§ Data are from the National Vital Statistics System (NVSS). Data for death rates cover 100% of the U.S. population. Use caution when comparing incidence and death rates because of potential differences in population coverage.

Top

Return to your place in the textTABLE 13. Reported number of cancer deaths, all cancer sites combined, by state — United States, 2004–2013*
State2004200520062007200820092010201120122013
Alabama9,7569,9139,89910,02510,18210,28910,19610,23310,27410,328
Alaska7287327908398678958849359251,016
Arizona9,6189,8209,91810,13310,08110,27110,67810,69011,08511,347
Arkansas6,3046,3616,1776,3886,5266,5136,4756,4976,5406,688
California53,70054,72954,14055,01154,68655,99056,45356,44857,67557,714
Colorado6,1966,3956,5506,6176,7196,9507,0357,0517,3067,357
Connecticut7,1747,0527,0446,8276,8306,8196,9546,8376,6816,619
Delaware1,8271,7991,7801,8521,9121,8131,9091,9051,9351,905
District of Columbia1,1521,1501,1781,1691,1431,1311,0411,0701,0811,095
Florida39,84040,59240,41540,08840,81440,93141,46741,68142,18742,734
Georgia14,31314,35814,47414,98314,62115,13915,43515,60216,02016,417
Hawaii2,0882,1692,1712,2142,1942,2442,2662,2782,2842,332
Idaho2,2272,3682,3062,4052,5112,4582,5302,5732,5722,707
Illinois24,28924,25024,08324,11324,29824,18224,07024,00624,56224,491
Indiana12,55212,79612,90312,77813,13613,09313,16413,18013,36813,258
Iowa6,3406,4536,3596,3766,4246,2496,3586,4816,4386,509
Kansas5,3125,4285,3435,4065,2945,3195,3775,4405,4295,379
Kentucky9,1599,5059,3949,6929,5899,6349,9309,73310,01210,082
Louisiana9,4349,2498,8538,7369,1979,0989,2039,2339,3089,419
Maine3,1243,2183,0893,1123,0933,1333,2473,2013,2263,227
Maryland10,16810,37110,35010,17910,36010,41210,26810,24910,52410,608
Massachusetts13,33713,18213,40713,00313,03113,11212,99312,89512,86412,858
Michigan19,65320,09420,19220,08720,21120,25720,62020,42020,49620,367
Minnesota9,0938,8239,0799,1769,4469,5809,6129,4899,4249,601
Mississippi5,9836,0656,2366,0016,1656,1306,2716,2786,4966,527
Missouri12,44912,41712,51912,38012,52212,47212,62612,47312,91912,955
Montana1,8671,9561,9431,9211,8621,9141,9232,0221,9541,997
Nebraska3,2703,3553,4303,4793,3763,3363,4383,4103,4793,459
Nevada4,1194,2384,2254,3314,4044,4614,5294,6054,6104,817
New Hampshire2,5542,5492,5342,6092,5762,5622,5252,7402,6602,584
New Jersey17,20617,17117,18017,09616,87416,54016,81516,70816,48316,315
New Mexico3,0353,1413,1473,2363,3553,2023,3583,3283,4613,481
New York36,10035,55535,28335,48535,35135,21535,43135,46935,88135,735
North Carolina16,47716,72417,31817,47817,45317,51318,06018,28418,40518,589
North Dakota1,2651,3021,3871,2641,3541,2431,2691,3211,2531,286
Ohio24,94024,70224,97525,23024,99825,14925,08325,14025,26124,986
Oklahoma7,2697,4467,4917,7277,6577,6397,8317,9978,0408,039
Oregon7,2367,3267,3097,3937,4797,4877,6387,8027,8327,799
Pennsylvania29,42229,61529,17029,01328,96328,87929,05528,89528,90728,512
Rhode Island2,4182,2912,2502,2132,2272,2202,2662,1702,1482,326
South Carolina8,3488,6528,8538,8679,1999,1239,3569,5439,7289,745
South Dakota1,5551,6121,5701,6121,5701,5031,6551,6651,6301,577
Tennessee12,58612,99513,05113,16113,16213,48213,59313,56213,76513,953
Texas33,93734,29134,93835,07435,71235,59136,71737,35138,14238,412
Utah2,4452,5202,6152,5722,4922,5552,8102,7462,8762,971
Vermont1,2121,2021,2141,3461,2791,2541,3921,3471,3251,318
Virginia13,38413,87713,82814,00913,98314,12214,07814,37414,29414,414
Washington10,98911,04811,05511,56811,61811,92211,87412,00211,95111,928
West Virginia4,6944,6174,6134,6904,6054,7864,6854,7824,6844,718
Wisconsin10,86110,94310,92510,96311,18510,86611,27911,60811,25211,425
Wyoming8758869279408749361,016936955946

*Data are from the National Vital Statistics System (NVSS).

Top

Return to your place in the textTABLE 14. Reported rate* of cancer deaths, all cancer sites combined, by state — United States, 2004–2013
State2004200520062007200820092010201120122013
Alabama204.6204.7199.8198.5197.3196.3190.7187.4184.8182.1
Alaska185.9173.3179.7185.2183.2186.5178.4176.4169.1173.1
Arizona167.4164.2160.0158.8153.2152.0152.6148.3148.1146.4
Arkansas208.3207.5196.6201.0201.1198.0193.7191.2188.6189.6
California169.4169.2164.8163.9158.9158.8155.8151.8150.7146.6
Colorado159.9160.5158.4154.7151.2151.9148.8144.2143.7139.2
Connecticut182.0176.7175.3167.0164.7162.8162.4158.1152.0147.8
Delaware208.0199.1190.6193.3192.7178.0184.4179.8176.2167.1
District of Columbia206.2206.2210.8208.8201.8196.9178.4180.8178.4177.7
Florida178.9177.9174.2169.3168.8165.9163.8160.0157.6154.9
Georgia196.3190.8184.9186.1175.7176.3173.9171.0169.6168.1
Hawaii150.2151.4148.2147.5142.0141.3140.5138.6134.4134.9
Idaho169.8174.7163.6166.5166.9159.0158.6157.7152.2156.3
Illinois194.9192.4188.9186.6185.0181.7177.9174.7175.4171.7
Indiana199.2200.0198.0192.9194.4190.4187.6185.2184.2179.4
Iowa181.8183.1178.6176.5176.4169.6170.7172.4167.9168.2
Kansas182.8185.5180.0178.6173.1171.5170.4170.1167.7162.9
Kentucky215.8219.5212.5215.0208.0204.8207.4200.9201.2199.3
Louisiana216.6215.4206.9199.2205.8198.6196.4193.5190.4188.7
Maine202.1204.8192.8189.8184.6185.4186.6181.7179.0174.8
Maryland190.9190.7187.4180.9180.6176.7170.2166.0165.9163.0
Massachusetts189.8186.0187.3179.2176.9175.3170.0166.7163.3159.7
Michigan191.1192.7190.8186.4184.5182.0182.0177.4174.3170.2
Minnesota176.8169.1171.0168.4170.3168.7166.1160.5155.6155.1
Mississippi210.2211.3213.2201.9202.8199.7200.4196.7200.0196.5
Missouri201.0197.9195.9190.9189.5185.4184.7179.4182.0179.1
Montana179.2184.3177.9170.9161.2162.8159.9164.6154.2154.0
Nebraska173.6175.1176.7176.3169.9164.7166.6164.3164.7160.7
Nevada192.5191.7185.5181.3179.8175.6173.5170.3163.7164.9
New Hampshire195.5189.9184.3185.1177.6173.3167.7177.9167.9158.6
New Jersey186.9185.0183.2179.8175.0168.8168.7165.7160.1156.0
New Mexico162.5163.1158.8158.3160.7149.0151.3146.7147.8145.1
New York177.7173.5171.1169.7166.6163.9162.1159.6159.4155.5
North Carolina194.0191.6191.8187.3181.3177.0177.9174.8170.4167.7
North Dakota166.2169.9179.8162.3171.2155.6156.1160.4150.6150.8
Ohio202.1198.1197.5196.3191.6190.1186.6184.5182.1177.4
Oklahoma196.0198.0195.3198.5193.0189.3190.4191.2189.4185.4
Oregon188.8186.8181.4178.7176.8172.5172.8172.4168.2163.2
Pennsylvania195.7195.2190.3186.4184.1181.7180.5177.4174.8170.0
Rhode Island196.4186.5181.8177.8177.5173.7176.7168.5163.3173.9
South Carolina195.9198.3195.0188.4190.3182.8182.6182.3179.1174.0
South Dakota177.3181.7172.7174.1167.9158.4169.8168.6162.1154.1
Tennessee208.4210.6205.0201.6197.1197.7194.6189.1187.8185.4
Texas182.6179.5176.7172.3170.4164.8165.1162.5160.3156.9
Utah141.0141.0140.2133.6125.8124.9133.0125.6128.8127.9
Vermont180.1176.1173.2188.7176.2169.2182.6175.9164.7164.1
Virginia189.0190.6185.8184.1179.4176.4171.7170.8165.2162.3
Washington184.9181.4175.9179.4175.9175.1169.7166.9161.8156.3
West Virginia212.3207.6204.0204.3197.9203.3196.6199.7191.1190.5
Wisconsin184.6182.9180.1177.3177.8169.5173.8174.8166.0164.6
Wyoming172.1169.3174.5173.4157.0163.8170.1155.9154.2147.7

*Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
Data are from the National Vital Statistics System (NVSS).

Top

Suggested citation for this article: Singh SD, Henley SJ, Ryerson AB. Surveillance for Cancer Incidence and Mortality — United States, 2013. MMWR Surveill Summ 2017;66(No. SS-4):1–36. DOI: http://dx.doi.org/10.15585/mmwr.ss6604a1.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

Top